UC Davis Health System
|
News
|
Jobs
|
Giving to UC Davis
Clinical Trials at UC Davis Health System
Health System
>
Clinical Trials
> Active Clinical Trials
Clinical Trials
FAQs
Participants' Bill of Rights
Search Clinical Trials
Research
Contact Us
Active Clinical Trials
All Trials
Recruiting Trials
Update trial listing
Principal Investigator
Title
Department
Gandara, David
A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Cancer Center
Gandara, David
MARVEL: Marker Validation of Erlotinib in Lung Cancer, A Phase III Biomarker Validation Study of Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Randomized to Pemetrexed Versus Erlotinib
Cancer Center
Valicenti, Richard
A Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy
Cancer Center
Ducore, Jonathan
Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies
Cancer Center
Welborn, Jeanna
Phase IIB, Multicenter, Randomized, Open-Label Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Intensive Salvage Therapy in Adult Patients ≤60 Years Old with AML in First Relapse Following an Initial CR >1 Month Duration
Cancer Center
Calhoun, Royce
A Randomized Phase III Study of Sublobar Resection versus Sublobar Resection Plus Brachytherapy in High Risk Patients with Non-Small Cell Lung Cancer (NSCLC), 3 cm or Smaller
Cancer Center
Ducore, Jonathan
Randomized Study of Chimeric Anti-GD-2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Cancer Center
Gandara, David
A Phase II Trial of CCI-779 and Bevacizumab in Patients with Endometrial, Ovarian, Hepatocellular carcinoma, Carcinoid or Islet Cell Cancer (NCI #8233)
Cancer Center
Chew, Helen
CCRC: A Phase 1 Study of Chronically-Dosed, Single-Agent ABT-888 in Patients with Either BRCA 1/2 Mutated Cancer; Platinum-Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer; or Basal-Like Breast Cancer (NCI #8282)
Cancer Center
Lara Jr, Primo
CCRC: A Phase II Selection Design of Pharmacodynamic Separation of Carboplatin/Paclitaxel/OSI-774 (Erlotinib; NSC-718781) or OSI-774 Alone in Advanced Non-Small Lung Cancer (NSCLC) Patients with Performance Status 2 (PS-2) Selected by Serum Proteomics
Cancer Center
Smith, Lloyd
Predicting Aromatase Inhibitor Responsiveness In Endometrial Carcinoma
MED: OBSTETRICS & GYNECOLOGY
Lara Jr, Primo
CCRC: A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration-Resistant Prostate Cancer
Cancer Center
Agius, Mark
CCRC: A Phase II, Double-Blind, Randomized, Multi-Center, Adaptive Dose-Ranging, Placebo-Controlled, Parallel-Group Study Evaluating Safety, Tolerability And Efficacy on MRI Lesion Parameters And Determining The Dose Response Curve Of BAF312 Given Orally Once Daily In Patients With Relapsing-Remitting Multiple Sclerosis [CBAF312A2201, version date 01/12/09] BOLD Study
MED: NEUROLOGY
Welborn, Jeanna
Phase IIB, Multicenter, Randomized, Open Label Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Cytarabine and Daunorubicin in Patients with Untreated AML 60-75 Years of Age
Cancer Center
Ducore, Jonathan
Treatment for Very Low, Low and Standard Risk Favorable Histology Wilms Tumor
Cancer Center
Zwerdling, Theodore
Treatment for Very Low, Low and Standard Risk Favorable Histology Wilms Tumor
Cancer Center
Gandara, David
CCRC: A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction (NCI #8063)
Cancer Center
Satake, Noriko
Development of Leukemia Stem Cell Targeted Therapy in Childhood Leukemia
Cancer Center
Ducore, Jonathan
Hodgkin Disease (HD) Banking Study
Cancer Center
Zwerdling, Theodore
Hodgkin Disease (HD) Banking Study
Cancer Center
Chen, Allen
A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer who are Treated without Surgery
Cancer Center
Agius, Mark
CCRC: A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing The Efficacy And Safety Of 1.25mg FTY720 Administered Orally Once Daily Versus Placebo In Patients With Primary Progressive Multiple Sclerosis [CFTY720D2306, version 8/28/2009]
MED: NEUROLOGY
Chen, Allen
A Phase II Trial of Sterotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer
Cancer Center
Tuscano, Joseph
An Open-Label, Single-Arm Phase II Study of RAD001 in Patients with Refractory Mantle Cell Lymphoma (EUDRACT 2007-005700-40)
Cancer Center
Ducore, Jonathan
Intensified Methotrexate, Nelarabine (Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL)
Cancer Center
<< First Page
< Previous
Page 1 of 10
Next >
Last Page >>
